Mitochondrial Donation: An 18 Month Outcome Study.

Status Recruiting

Clinical Trial Summary

The Investigator proposes to record the fetal and postnatal development of children conceived using Mitochondrial Donation (MD) and to perform expert assessment of development at 18 months (corrected for gestational age) using the internationally validated Bayley-III developmental assessment tool.

Clinical Trial Description

To record the fetal and postnatal development of children conceived using Mitochondrial Donation and to perform internationally validated Bayley-III developmental assessment tool at 18 months (corrected for gestational age). The null hypothesis for this research is that children born following the use of Mitochondrial Donation (IVF) techniques have normal neurodevelopment developmental outcomes at 18 months. ;

Study Design

Related Conditions & MeSH terms

Mitochondrial Diseases

Clinical Trial Details

NCT number	NCT04113447
Study type	Observational
Source	Newcastle-upon-Tyne Hospitals NHS Trust
Contact
Status	Recruiting
Phase
Start date	November 1, 2017
Completion date	January 1, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03388528` - Low Residue Diet Study in Mitochondrial Disease	N/A
Completed	`NCT04378075` - A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy	Phase 2/Phase 3
Completed	`NCT03678740` - Diagnostic Odyssey Survey 2
Recruiting	`NCT06051448` - Promoting Resilience in Stress Management (PRISM) and Clinical-focused Narrative (CFN) Pilot in Adults With Primary Mitochondrial Disease (PMD).	Phase 1/Phase 2
Completed	`NCT02909400` - The KHENERGY Study	Phase 2
Completed	`NCT02398201` - A Study of Bezafibrate in Mitochondrial Myopathy	Phase 2
Completed	`NCT03857880` - Identification of New Candidate Genes in Patients With Mitochondrial Disease by High Resolution Chromosome Analysis on DNA Chip
Completed	`NCT04165239` - The KHENERGYZE Study	Phase 2
Completed	`NCT02284334` - Glycemic Index in Mitochondrial Disease
Recruiting	`NCT06080581` - Mitochondrial Dysfunctions Driving Insulin Resistance
Recruiting	`NCT06080568` - Human Mitochondrial Stress-driven Obesity Resistance
Recruiting	`NCT04802707` - Deoxynucleosides Pyrimidines as Treatment for Mitochondrial Depletion Syndrome	Phase 2
Completed	`NCT04580979` - Natural History Study of FDXR Mutation-related Mitochondriopathy
Completed	`NCT04594590` - Natural History Study of SLC25A46 Mutation-related Mitochondriopathy
Withdrawn	`NCT03866954` - Trial of Erythrocyte Encapsulated Thymidine Phosphorylase In Mitochondrial Neurogastrointestinal Encephalomyopathy	Phase 2
Enrolling by invitation	`NCT04734626` - CrCest Study in Primary Mitochondrial Disease
Completed	`NCT03832218` - Executive Function Disorders and Anxio-depressive Symptomatology in Children and Adolescents With Mitochondrial Pathologies	N/A
Terminated	`NCT02473445` - A Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Capsules (RP103) in Children With Inherited Mitochondrial Disease	Phase 2
Recruiting	`NCT05012358` - Genomic Profiling of Mitochondrial Disease - Imaging Analysis for Precise Mitochondrial Medicine
Recruiting	`NCT04920812` - MITOMICS : a Multi-OMICS Approach for the Diagnosis of Mitochondrial Diseases